MedPath

Ultrasound-guided Adductor Canal Block for Total Knee Replacement

Phase 4
Completed
Conditions
Knee Injuries
Complications; Arthroplasty
Interventions
Drug: Preservative free normal saline
Registration Number
NCT02100579
Lead Sponsor
Northwestern University
Brief Summary

Total knee arthroplasty is associated with intense early postoperative pain. Fast track recovery programs including early therapy protocols and early hospital discharge are being implemented at various hospitals. The postoperative analgesic pain regimen should enhance functional recovery in addition to providing efficient analgesia with minimal side effects. Adductor canal blockade is commonly used to provide postoperative analgesia for total knee arthroplasty (TKA) surgery. The investigators hypothesize that an ultrasound guided adductor canal block will lower narcotic consumption and improved overall satisfaction compared to ultrasound guided sham block with normal saline (placebo) for patients undergoing minimally invasive TKA surgery.

Detailed Description

The investigators hypothesize that an ultrasound guided adductor canal block will lower narcotic consumption and improved overall satisfaction compared to ultrasound guided sham block with normal saline (placebo) for patients undergoing minimally invasive TKA surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Participants 40 to 75 years old who are presenting for minimally invasive total knee arthroplasty under spinal anesthesia
Exclusion Criteria
  • Patient refusal
  • American Society of Anesthesiologists physical status classification of 4 or higher
  • Pre-existing neuropathy in the femoral or sciatic distribution
  • Coagulopathy
  • Infection at the site
  • Chronic opioid use (greater than 3 months)
  • Pregnancy
  • Medical conditions limiting physical therapy participation
  • Any other contra-indication to regional anesthesia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control GroupPreservative free normal salineUltrasound-guided sham block with 10 ml of preservative free normal saline
Active GroupBupivacaineUltrasound-guided adductor canal blockade with 10 ml of 0.25% bupivacaine
Primary Outcome Measures
NameTimeMethod
Opioid Consumption (mg morEq)36 hours

Opioid consumption (morphine equivalents)

Secondary Outcome Measures
NameTimeMethod
Length of Hospitalization0 to 192 hours

The average time to discharge in hours. Participants were discharged home went physical therapy criteria were met.

Visual Analog Scale Pain ScorePain burden at 36hr

Visual Analog Scale pain score; 0 = no pain, 10 = excruciating pain) in the knee recorded every 6 hours up to 36hrs following surgery.

Trial Locations

Locations (1)

Northwestern University Feinberg School of Medicine

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath